WEN LEANA — SEC Form 4 filings
SEC reporting owner CIK 1847598. 11 Form 4 filings on record with FilingPulse; latest filed 2026-08-03.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-06-03 to 2026-08-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 2,225 shares, $331,701 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 1,700 shares @ $143.35 ($243,695) in GLAUKOS Corp, filed 2026-05-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| GLAUKOS Corp (GKOS) | Director | 7 | — | 2 legs · 2,225 sh · $331,701 | 9 |
| UroGen Pharma Ltd. (URGN) | Director | 4 | — | — | 7 |
Form 4 filings — WEN LEANA
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-03 | 4 | GLAUKOS Corp (GKOS) | Sale (S): 525 @ $167.63 | EDGAR |
| 2026-06-24 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4/A | GLAUKOS Corp (GKOS) | Grant/award (A): 2,987 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 1,878 @ $0 · Grant/award (A): 2,987 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | GLAUKOS Corp (GKOS) | Sale (S): 1,700 @ $143.35 | EDGAR |
| 2026-01-07 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 623 @ $0 | EDGAR |
| 2025-12-01 | 4 | UroGen Pharma Ltd. (URGN) | Option exercise (M): 2,000 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 461 @ $0 · Grant/award (A): 2,108 @ $0 · Grant/award (A): 3,149 (derivative) @ $0 | EDGAR |
| 2024-08-08 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 1,716 @ $0 · Grant/award (A): 1,246 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1847598 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →